About Lina Williamson
Lina Williamson is co-founder and CEO of Soterya, the Boston company that makes the Korus repositioning bed. The National Institutes of Health has funded Soterya's epilepsy work since 2021. Lina Williamson has more than 20 years of experience in translational medicine, strategic partnerships and venture building.
She was head of entrepreneurship at Hospital Clínic de Barcelona and, in 2023, a fellow of the Catalyst program at MIT linQ. Earlier she founded and directed the Translational Accelerator at Brigham and Women's Hospital, which produced seven startups and two licenses. She also worked at Novartis and TMA Precision Health.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Lina Williamson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Lina Williamson works with at each company, as listed on that company's latest Form D.
Lina Williamson in the News
- Insights From LSI Europe '23: How the Largest Challenges in Hospitals Are Being Addressed by Emerging Technologies
- First edition of d·Health Barcelona Part Time ends with Graduation Day
- barnaclínic+ participates in the II Campus Clínic Innovation Awards
- Nuritas Brings Industry Pharma Thought Leaders Together to Accelerate Drug Discovery with AI
- Men's Health Month: The Future of Digital Fertility
Sources
- SECSoterya, Inc. Form D, filed Oct 13, 2026
- University sitePeople list, Catalyst at MIT linQ (Fellow 2023)
- Government sitePubMed record of an Am J Lifestyle Med paper, 2024 (affiliation: Head of Entrepreneurship, Hospital Clinic Barcelona)
- University siteAuthor affiliations ('TMAcceletator company LLC (TMA Precision Health)', Boston) in supplementary materials of an IEEE OJEMB 2020 paper, Politecnico di Torino repository